Researchers Discover Drug can Prevent Colon Cancer Development in Mice

February 12, 2009

Researchers at the Mayo Clinic campus in Florida have found that a drug now being tested to treat a range of human cancers significantly inhibited colon cancer development in mice. Because the agent appears to have minimal side effects, it may represent an effective chemopreventive treatment in people at high risk for colon cancer, the investigators say.

Their study, published in the Feb. 15 issue of Cancer Research, found that use of the agent, enzastaurin, significantly reduced development of cancerous colon tumors in treated animals. Furthermore, the tumors that did develop in the mice were of a lower grade, which meant they were less advanced and aggressive than the tumors seen in animals not given the drug.

"There is need for an agent that has a proven ability to reduce colon cancer risk, and this study suggests that enzastaurin could be uniquely effective," says the study's senior investigator, Nicole Murray, Ph.D., of the Department of Cancer Biology.

Individuals at high risk for colon cancer often develop numerous precancerous colon polyps, which must be periodically removed during a colonoscopy, Dr. Murray says.

The laboratories of Dr. Murray, and her collaborator and co-author, Alan Fields, Ph.D., chair of the Department of Cancer Biology, focus on characterizing the genes involved in different stages of colon carcinogenesis. They have zeroed in on the protein kinase C (PKC) family of enzymes as major players in cancer development and progression, but it has taken them years to understand the different roles of each type of PKC molecule or "isozyme."

"All PKC isozymes act in essentially the same way. They add phosphate groups to proteins to change the function of the protein, but within cells we find that each PKC isozyme plays a different role," Dr. Murray says.

Using transgenic mice in which different PKC genes have been selectively deleted or silenced, the researchers have determined pivotal roles for two of the major isozymes. In the Jan. 15 issue of Cancer Research, they reported that PKCß (PKC-beta) is necessary for initiation of colon cancer in mice exposed to a carcinogen. "These mice develop colon tumors similar to tumors found in humans, but mice without a PKCß gene do not," Dr. Murray says.

In that study, they also demonstrated that a different PKC isozyme known as PKCi/l (PKC iota-lambda) is involved in progression of colon cancer. If the PKCi/l gene is deleted in mice models that mimic the type of cancer seen in people with an inherited form of colon cancer, the cancer doesn't progress at such a rapid rate, Dr. Murray says. "But in those same mice, if we knock out the PKCß gene, there is no effect," she says.

"This tells us that over-expression of PKCß and PKCi/l serve distinct, nonoverlapping roles in colon carcinogenesis, conspiring to drive initiation and progression of colon carcinogenesis, respectively," Dr. Murray says.

Those findings suggested that targeting these different PKC isozymes could have distinct cancer treatment benefits. Targeting PKCß in colon cells could help prevent initial cancer development, and inhibiting PKCi/l might help stop progression of cancer that has already developed, she says.

In the current study, the research team tested enzastaurin, an oral drug specifically designed to suppress signaling through the PKCß pathway. The drug is now in clinical trials to treat B-cell lymphoma and high-grade brain gliomas, among other cancers.

Researchers gave the agent daily to one group of mice, and then exposed this group, as well as a control group of mice, to a carcinogen that produces colon tumors. After 22 weeks, 80 percent of mice in the control group developed colon tumors, but only 50 percent of the treated mice developed tumors, and the cancers that developed were not as advanced, Dr. Murray says.

The agent could be tested for colon cancer chemoprevention in a fairly simple manner, Dr. Murray says. Because precancerous colon polyps can be observed during a colonoscopy, it would be possible to see if a drug that targeted PKCß reduced polyp formation over time in people who are using the agent, she says.

Source: Mayo Clinic


Rank not rated yet
Relevant PhysicsForums posts
  • Is Everyday Technology Killing Us?
    createdFeb 08, 2012
  • Exercise and weight loss
    createdFeb 08, 2012
  • Why do we have head aches? Our brains can't feel anything.
    createdFeb 07, 2012
  • "The end of diseases" by David Agus, interview from Daily Show with Jon Stewart
    createdFeb 04, 2012
  • Oncolytic adenovirus
    createdFeb 04, 2012
  • Nutrition label stuffs and diets
    createdFeb 02, 2012
  • More from Physics Forums - Medical Sciences

More news stories

Starve a virus, feed a cure? Findings show how some cells protect themselves against HIV

A protein that protects some of our immune cells from the most common and virulent form of HIV works by starving the virus of the molecular building blocks that it needs to replicate, according to research published online ...

Medicine & Health / Research

created 1 hour ago | popularity 5 / 5 (1) | comments 0 | with audio podcast

Injured boomers beware: Know when to see doctor

(AP) -- It happened to nurse Jane Byron years after an in-line skating fall, business owner Haralee Weintraub while doing "men's" push-ups, and avid cyclist Gene Wilberg while lifting a heavy box.

Medicine & Health / Health

created 3 hours ago | popularity 5 / 5 (1) | comments 0

FDA-approved drug rapidly clears amyloid from the brain, reverses Alzheimer's symptoms in mice

Neuroscientists at Case Western Reserve University School of Medicine have made a dramatic breakthrough in their efforts to find a cure for Alzheimer's disease. The researchers' findings, published in the journal Science, show t ...

Medicine & Health / Neuroscience

created Feb 09, 2012 | popularity 4.9 / 5 (55) | comments 21 | with audio podcast

Green tea found to reduce disability in the elderly

(Medical Xpress) -- A lot of research has been done over the past several years looking into the health benefits of green tea. As a result, scientists have found that regular consumption of the beverage leads ...

Medicine & Health / Health

created Feb 07, 2012 | popularity 4.4 / 5 (14) | comments 11 | with audio podcast report

Teen school drop-outs three times as likely to be on benefits in later life

Teen school drop-outs are almost three times as likely to be on benefits in later life as their peers who complete their schooling, indicates research published online in the Journal of Epidemiology and Community Health.

Medicine & Health / Health

created Feb 06, 2012 | popularity not rated yet | comments 13


Scientists discover molecular secrets of 2,000-year-old Chinese herbal remedy

For roughly two thousand years, Chinese herbalists have treated Malaria using a root extract, commonly known as Chang Shan, from a type of hydrangea that grows in Tibet and Nepal. More recent studies suggest that halofuginone, ...

New method to examine batteries -- MRI from the inside

There is an ever-increasing need for advanced batteries for portable electronics, such as phones, cameras, and music players, but also to power electric vehicles and to facilitate the distribution and storage of energy derived ...

Lab study raises questions over nano-particle impact

Tests involving chickens have raised questions about the impact on health from engineered nano-particles, the ultra-fine grains commonly used in drugs and processed foods, scientists said on Sunday.

A mitosis mystery solved: How chromosomes align perfectly in a dividing cell

Although the process of mitotic cell division has been studied intensely for more than 50 years, Whitehead Institute researchers have only now solved the mystery of how cells correctly align their chromosomes during symmetric ...

Researchers find extensive RNA editing in human transcriptome

In a new study published online in Nature Biotechnology, researchers from BGI, the world's largest genomics organization, reported the evidence of extensive RNA editing in a human cell line by analysis of RNA-seq data, demons ...

The proteins ensuring genome protection

Researchers from the University of Geneva (UNIGE), Switzerland, have discovered the crucial role of two proteins in developing a cell 'anti-enzyme shield'. This protection system, which operates at the level of molecular ...